Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2045-2322

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence ; volume:8 ; number:1 ; day:30 ; month:10 ; year:2018 ; pages:1-7 ; date:12.2018
Scientific reports ; 8, Heft 1 (30.10.2018), 1-7, 12.2018

Creator: Lin, Pei-Tzu
Wang, Shu-Hui
Chi, Ching-Chi

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41598-018-34293-y

URN: urn:nbn:de:101:1-2018121400023394985899

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:04 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Lin, Pei-Tzu
Wang, Shu-Hui
Chi, Ching-Chi
SpringerLink (Online service)

Other Objects (12)

Evidenz-basierte Therapie der Psoriasis : Schwerpunkt Biologics

Hochschulschrift

Autoimmunphänomene in der Therapie der Psoriasis mit Biologics

Evidence-based therapy of Psoriasis: focus on biologics

Biologics als neue Therapieoptionen in der Behandlung der Psoriasis und Psoriasis-Arthritis

Prevalence of antiphospholipid autoantibodies associated with biologics treatment for psoriasis

Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-World Studies

Factors Affecting Treatment Persistence in Japanese Patients with Psoriasis Prescribed Biologics: A Real-World Study Using an Insurance Claim Database

Residual metabolic burden in young psoriasis patients successfully treated with biologics

Dose Tapering of Biologics in Patients with Psoriasis: A Scoping Review

Real-world retention rates of biologics in patients with rheumatoid arthritis

Adjunctive Use of Calcipotriene/Betamethasone Dipropionate Foam in a Real-World Setting Curtails the Cost of Biologics Without Reducing Efficacy in Psoriasis

Evidenz-basierte Therapie der Psoriasis : Schwerpunkt Biologics

Hochschulschrift

Autoimmunphänomene in der Therapie der Psoriasis mit Biologics

Evidence-based therapy of Psoriasis: focus on biologics

Biologics als neue Therapieoptionen in der Behandlung der Psoriasis und Psoriasis-Arthritis

Prevalence of antiphospholipid autoantibodies associated with biologics treatment for psoriasis

Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-World Studies

Factors Affecting Treatment Persistence in Japanese Patients with Psoriasis Prescribed Biologics: A Real-World Study Using an Insurance Claim Database

Residual metabolic burden in young psoriasis patients successfully treated with biologics

Dose Tapering of Biologics in Patients with Psoriasis: A Scoping Review

Real-world retention rates of biologics in patients with rheumatoid arthritis

Adjunctive Use of Calcipotriene/Betamethasone Dipropionate Foam in a Real-World Setting Curtails the Cost of Biologics Without Reducing Efficacy in Psoriasis

Evidenz-basierte Therapie der Psoriasis : Schwerpunkt Biologics

Hochschulschrift

Autoimmunphänomene in der Therapie der Psoriasis mit Biologics

Evidence-based therapy of Psoriasis: focus on biologics

Biologics als neue Therapieoptionen in der Behandlung der Psoriasis und Psoriasis-Arthritis

Prevalence of antiphospholipid autoantibodies associated with biologics treatment for psoriasis

Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-World Studies

Factors Affecting Treatment Persistence in Japanese Patients with Psoriasis Prescribed Biologics: A Real-World Study Using an Insurance Claim Database

Residual metabolic burden in young psoriasis patients successfully treated with biologics

Dose Tapering of Biologics in Patients with Psoriasis: A Scoping Review

Real-world retention rates of biologics in patients with rheumatoid arthritis

Adjunctive Use of Calcipotriene/Betamethasone Dipropionate Foam in a Real-World Setting Curtails the Cost of Biologics Without Reducing Efficacy in Psoriasis

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Evidenz-basierte Therapie der Psoriasis : Schwerpunkt Biologics

Evidenz-basierte Therapie der Psoriasis : Schwerpunkt Biologics

Autoimmunphänomene in der Therapie der Psoriasis mit Biologics

Evidence-based therapy of Psoriasis: focus on biologics

Biologics als neue Therapieoptionen in der Behandlung der Psoriasis und Psoriasis-Arthritis

Prevalence of antiphospholipid autoantibodies associated with biologics treatment for psoriasis

Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-World Studies

Factors Affecting Treatment Persistence in Japanese Patients with Psoriasis Prescribed Biologics: A Real-World Study Using an Insurance Claim Database

Residual metabolic burden in young psoriasis patients successfully treated with biologics

Dose Tapering of Biologics in Patients with Psoriasis: A Scoping Review

Real-world retention rates of biologics in patients with rheumatoid arthritis

Adjunctive Use of Calcipotriene/Betamethasone Dipropionate Foam in a Real-World Setting Curtails the Cost of Biologics Without Reducing Efficacy in Psoriasis

Evidenz-basierte Therapie der Psoriasis : Schwerpunkt Biologics

Evidenz-basierte Therapie der Psoriasis : Schwerpunkt Biologics

Autoimmunphänomene in der Therapie der Psoriasis mit Biologics

Evidence-based therapy of Psoriasis: focus on biologics

Biologics als neue Therapieoptionen in der Behandlung der Psoriasis und Psoriasis-Arthritis

Prevalence of antiphospholipid autoantibodies associated with biologics treatment for psoriasis

Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-World Studies

Factors Affecting Treatment Persistence in Japanese Patients with Psoriasis Prescribed Biologics: A Real-World Study Using an Insurance Claim Database

Residual metabolic burden in young psoriasis patients successfully treated with biologics

Dose Tapering of Biologics in Patients with Psoriasis: A Scoping Review

Real-world retention rates of biologics in patients with rheumatoid arthritis

Adjunctive Use of Calcipotriene/Betamethasone Dipropionate Foam in a Real-World Setting Curtails the Cost of Biologics Without Reducing Efficacy in Psoriasis

Evidenz-basierte Therapie der Psoriasis : Schwerpunkt Biologics

Evidenz-basierte Therapie der Psoriasis : Schwerpunkt Biologics

Autoimmunphänomene in der Therapie der Psoriasis mit Biologics

Evidence-based therapy of Psoriasis: focus on biologics

Biologics als neue Therapieoptionen in der Behandlung der Psoriasis und Psoriasis-Arthritis

Prevalence of antiphospholipid autoantibodies associated with biologics treatment for psoriasis

Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-World Studies

Factors Affecting Treatment Persistence in Japanese Patients with Psoriasis Prescribed Biologics: A Real-World Study Using an Insurance Claim Database

Residual metabolic burden in young psoriasis patients successfully treated with biologics

Dose Tapering of Biologics in Patients with Psoriasis: A Scoping Review

Real-world retention rates of biologics in patients with rheumatoid arthritis

Adjunctive Use of Calcipotriene/Betamethasone Dipropionate Foam in a Real-World Setting Curtails the Cost of Biologics Without Reducing Efficacy in Psoriasis

Related objects

Reset password